BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36803208)

  • 1. Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?-A propensity score analysis.
    Ouyang H; Ma W; Jiang X; Gerdtsson AS; Liu D; Pan Z
    Expert Rev Gastroenterol Hepatol; 2023 Apr; 17(4):405-412. PubMed ID: 36803208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis.
    Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
    Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care.
    Ouyang H; Ma W; Liu F; Yue Z; Fang M; Quan M; Pan Z
    Pancreatology; 2017; 17(5):773-781. PubMed ID: 28734721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study.
    Yan X; Ning ZY; Wang P; Zhuang LP; Xu LT; Zhu ZF; Sheng J; Shen YH; Hua YQ; Meng ZQ
    Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):1047-1056. PubMed ID: 33356652
    [No Abstract]   [Full Text] [Related]  

  • 5. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
    Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
    BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database.
    Hamad A; Underhill J; Ansari A; Thayaparan V; Cloyd JM; Li Y; Pawlik TM; Tsung A; Abushahin L; Ejaz A
    Surgery; 2022 Jun; 171(6):1464-1470. PubMed ID: 35115154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.
    Andreou A; Knitter S; Klein F; Malinka T; Schmelzle M; Struecker B; Schmuck RB; Noltsch AR; Lee D; Pelzer U; Denecke T; Pratschke J; Bahra M
    Surg Oncol; 2018 Dec; 27(4):688-694. PubMed ID: 30449494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases.
    Ouyang H; Ma W; Zhang T; Liu F; Zhao L; Fang M; Quan M; Pan Z
    Pancreatology; 2018 Dec; 18(8):983-989. PubMed ID: 30287168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
    Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
    Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
    Tachezy M; Gebauer F; Janot M; Uhl W; Zerbi A; Montorsi M; Perinel J; Adham M; Dervenis C; Agalianos C; Malleo G; Maggino L; Stein A; Izbicki JR; Bockhorn M
    Surgery; 2016 Jul; 160(1):136-144. PubMed ID: 27048934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases.
    Wu L; Lu Y; Chen L; Yue X; Cen C; Zheng C; Han P
    Curr Oncol; 2022 Oct; 29(10):7912-7924. PubMed ID: 36290902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?
    Ebrahimi A; Cham J; Puglisi L; De Shadarevian M; Hermel DJ; Spierling Bagsic SR; Sigal D
    Cancer Med; 2023 May; 12(9):10243-10253. PubMed ID: 36916531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas.
    Downs-Canner S; Zenati M; Boone BA; Varley PR; Steve J; Hogg ME; Zureikat A; Zeh HJ; Lee KK
    J Surg Oncol; 2015 Jul; 112(1):80-5. PubMed ID: 26153355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.
    Yang J; Zhang J; Lui W; Huo Y; Fu X; Yang M; Hua R; Wang L; Sun Y
    HPB (Oxford); 2020 Jan; 22(1):91-101. PubMed ID: 31262486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for isolated liver metastases from pancreatic cancer.
    Zanini N; Lombardi R; Masetti M; Giordano M; Landolfo G; Jovine E
    Updates Surg; 2015 Mar; 67(1):19-25. PubMed ID: 25702263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.
    Decoster C; Gilabert M; Autret A; Turrini O; Oziel-Taieb S; Poizat F; Giovannini M; Viens P; Iovanna J; Raoul JL
    Oncotarget; 2016 Jul; 7(29):45649-45655. PubMed ID: 27286454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
    Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
    World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.